Cystic Fibrosis: causal treatment suitable from childhood
Earlier treatment means disease progression is likely to be significantly slowed.
Earlier treatment means disease progression is likely to be significantly slowed.
Under the direction of the BREATH scientist Prof. Dr. Burkhard Tümmler, the second edition of the monograph „Mutation-specific therapies in cystic fibrosis“ has now been published.
In a rare form of lung cancer, new molecular findings create the prerequisite for better understanding and therapeutic advances.
With triple therapy, the lungs of cystic fibrosis patients are better ventilated down to their most minor ramifications.
Lung transplantation is an established therapy option for children and young people with serious and progressive lung diseases without any other alternative treatment.
Dr. med. Jannik Ruwisch is one of the youngest new additions in the Department of Respiratory Medicine at Hannover Medical School.
SYNERGIE, the German Centers for Health Research magazine, has won the iF Design Award 2022 in the communication design category.
The DZL supports a position paper of the German Respiratory Society (DGP e. V.), which advises against using e-cigarettes. They are not a suitable aid for quitting smoking.
In her doctoral thesis, award winner Gizem Güneş Günsel investigated an enzyme that causes the progression of the lung disease COPD.
We, the German Centers for Health Research, consider the Russian invasion of Ukraine an attack on elementary values of freedom, democracy and self-determination, on which scientific freedom and opportunities for cooperation are based.
Physicians and researchers from the University Hospital of Munich (LMU) and CPC-M have demonstrated reduction of the fetal lung volume in mothers who had undergone an uncomplicated SARS-CoV-2 infection during pregnancy.
Thanks to million euro funding from the state of Hesse, Corona expert Susanne Herold remains at Justus Liebig University Giessen.
